title: [The treatment of diffuse euthyroid goiter with indomethacin].
abstract: Clinico-instrumental and hormonal investigation of 31 patients with diffuse euthyroid goiter was conducted. To test the efficacy of indometacin as an antigoitrogenic drug, these patients were given it for 2 mos. Combined examination of the patients showed the absence of thyroid decrease and changes in thyroid function against a background of indometacin monotherapy. The results point out to the fact that the drug should not be used for elimination of thyroid hyperplasia in persons with diffuse euthyroid goiter.
authors.forename: B Sh
authors.initials: BSh
authors.lastname: Tsitsiashvili
authors.forename: A Kh
authors.initials: AKh
authors.lastname: Mirkhodzhaeva
authors.forename: T N
authors.initials: TN
authors.lastname: Kalistratova
authors.forename: G A
authors.initials: GA
authors.lastname: Gaĭdina
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Maĭorov
mesh_terms: D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D006042:Goiter / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008875:Middle Aged; D013961:Thyroid Gland / Q000187:drug effects
chemical_list: D007213:Indomethacin
vernacular_title: Lechenie diffuznogo éutireoidnogo zoba indometatsinom.